No connection

Search Results

Earnings Score 45 Bearish

Novartis Q1 Revenue Dips as US Generic Competition Intensifies

Apr 28, 2026 09:27 UTC
NVS
Short term

Novartis reported a decline in first-quarter net sales and missed profit estimates. The results highlight the growing impact of generic competition on the company's core blockbuster portfolio.

  • Q1 net sales reached $13.1 billion, a 1% nominal decrease
  • Constant currency revenue saw a steeper decline of 5%
  • Profit figures failed to meet market expectations
  • Volume growth of 13 percentage points was offset by a 14 percentage point decline in other areas
  • Generic erosion in the US remains a primary headwind

Novartis (NVS) has seen its first-quarter financial performance weighed down by intensifying generic competition in the United States, leading to a miss on both profit and revenue expectations. The pharmaceutical giant is currently grappling with the erosion of its blockbuster drug margins, a common challenge for large-cap pharma as patents expire and lower-cost alternatives enter the market. This pressure has manifested in a top-line contraction that caught analysts by surprise. Net sales for the quarter totaled $13.1 billion, representing a 1% decline overall and a 5% drop on a constant currency basis. While volume growth contributed 13 percentage points to the top line, these gains were more than offset by a 14 percentage point drag, primarily attributed to pricing and generic pressures. The unexpected revenue decline and profit miss suggest that the transition to newer pipeline products may not yet be fully offsetting the losses from legacy assets. Investors are likely to focus on the company's ability to stabilize margins and accelerate the rollout of new therapies amidst ongoing pricing pressures in the US market.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 42 Bullish

Kimberly-Clark Reports Q1 Profit Growth and Revenue Increase

Apr 28, 10:45

Score 45 Bearish

UPS Beats Q1 Estimates Amid Strategic Transition and Volume Pressures

Apr 28, 10:35

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile